Anjana Pillai's Avatar

Anjana Pillai

@anjanapillaimd.bsky.social

Professor @UChicagoMed specializing in liver tumors and Liver Tx|#LDLT|PD Transplant Hep Fellowship|Director @HCCLIVEConf |Mommy of 2|Educator|Runner

244 Followers  |  75 Following  |  7 Posts  |  Joined: 04.12.2024  |  1.7022

Latest posts by anjanapillaimd.bsky.social on Bluesky

Post image Post image

Really important morning session on how to build the transplant fellowship work force across all organs- timely initiative - early exposure, mentorship, impact of work, work life resources all very important area of focus @ast-licop.bsky.social #WTC2025

05.08.2025 16:55 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Thank you for highlighting our paper @atoosarabiee.bsky.social
If you want some light liver cancer learning ;)

13.05.2025 23:59 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

πŸ”₯Nivolumab and Ipilimuma approved by EMA for advanced hepatocellular carcinoma πŸ”₯
πŸ‘‡https://ec.europa.eu/health/documents/community-register/html/h1014.htm
πŸ‘‰great news for our patients > more options in 1st line
πŸ˜…amazing: approval in πŸ‡ͺπŸ‡Ίby EMA before πŸ‡ΊπŸ‡Έby FDA
@myESMO @EASLedu @ILCAnews #livertwitter

04.03.2025 15:45 β€” πŸ‘ 12    πŸ” 6    πŸ’¬ 0    πŸ“Œ 0
Post image

Spicy!

Adding lasix to the management of hepatorenal syndrome might be ok if you bump the MAP with pressors

@juancarlosqvelez.bsky.social

doi.org/10.1016/j.ek...
#nephsky #liversky

04.03.2025 00:08 β€” πŸ‘ 26    πŸ” 9    πŸ’¬ 2    πŸ“Œ 0
Post image

Join ACG for the next Virtual Grand Roundsβ€”

ACG Clinical Guideline: Focal Liver Lesions
Reena J. Salgia, MD

Thursday, February 27 at Noon & 8pm ET
➑️ gi.org/ACGVGR

23.02.2025 12:00 β€” πŸ‘ 5    πŸ” 4    πŸ’¬ 0    πŸ“Œ 0
Post image Post image Post image

Every year I feel so fortunate to be part of this #LiverCancer community with these amazing friends who are true leaders sharing a common goal!! Amongst the beautiful chaos that is life, it’s important to find your passion and your people πŸ’š. That’s a wrap @hcclive.bsky.social

22.02.2025 23:09 β€” πŸ‘ 7    πŸ” 4    πŸ’¬ 0    πŸ“Œ 0
Post image

Registration is now open! We're so excited to welcome you to the 2025 HCC-LIVE Conference. See you at the Welcome Reception at 6:30!

20.02.2025 21:14 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Preview
DEI isn't racist. The people who say it is often are. As someone who has worked in "DEI," broadly speaking, for almost 15 years, here's what right-wing propagandists get so, so wrong and why we actually need DEI.

Seems like a good time to re-share my essay which has a whole section titled, β€œWhat, even, is β€˜DEI’?”

arghavan.substack.com/p/dei-isnt-r...

31.01.2025 02:30 β€” πŸ‘ 66    πŸ” 19    πŸ’¬ 2    πŸ“Œ 1
Post image

Kirema Garcia-Reyes is giving a Critical Assessment of EMERALD -1 at HCC Live! Make sure to attend this session for a review of data, treatment efficacy, and safety findings from the EMERALD-1 clinical study @kiremagarciamd

30.01.2025 19:12 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

Join the Debate: Drs. Riad Salem and Mishal Mendiratta-Lala Face Off on Histosonics vs. SBRT! Don’t miss this compelling discussion and more at HCC Live.

Enjoy 40% off registration until January 31st!
πŸ‘‰ Register now: loom.ly/7h0SJyM

30.01.2025 18:47 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

Dr. Tanios Bekaii- Saab is presenting at HCC Live! You wont want to miss this. Register now at loom.ly/7h0SJyM.

30.01.2025 19:05 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

Course Director Spotlight: Join Anjana Pillai, MD at the HCC-LIVE Conference - Space is Limited - Register Now!
@anjanapillaimd.bsky.social

30.01.2025 19:06 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

Read this

A review of reported adverse events for medications to treat alcohol use disorder

we must reduce alcohol use in people with liver disease

And to increase uptake of useful tools …

we need stop repeating that naltrexone is hepatotoxic

doi.org/10.1016/j.cg...

22.01.2025 01:35 β€” πŸ‘ 19    πŸ” 5    πŸ’¬ 3    πŸ“Œ 0

Hello #livertwitter friends- if you’re a liver cancer expert or want to be, please join us Feb 20-22 in Austin! We’d love to see you there! www.hcc-live.org @hcclive.bsky.social

22.01.2025 02:33 β€” πŸ‘ 2    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0
Post image

🎊Happy Holidays from your #HCC-LIVE conference crew! We are excited to see our fellow #livercancer enthusiasts in Austin Feb 20-22. We’d love for you to join our growing community!! Also submit your abstracts by 12/27 loom.ly/UBi8KDc

24.12.2024 19:27 β€” πŸ‘ 3    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Treating Patients, Not P Values To the dismay of many statisticians, clinicians are taught to convert continuous results into a binary value to facilitate decision-making. A person with a hemoglobin A1c level of 6.5% or higher ha...

Really good review for those of us who are not always digging into statistical methods #livertwitter

evidence.nejm.org/doi/full/10....

21.12.2024 15:22 β€” πŸ‘ 8    πŸ” 4    πŸ’¬ 0    πŸ“Œ 0

πŸŽ‰Happy holidays my fellow liver lovers I’m sure many of you have seen this but thought I’d leave this right here πŸ˜‰πŸŽ

www.instagram.com/share/BAEBdk...

16.12.2024 01:06 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Locoregional Therapies for Hepatocellular Carcinoma This systematic review and meta-analysis compares findings from randomized clinical trials on the use of locoregional therapies as monotherapy or combination therapy in the treatment of nonmetastatic ...

Systematic review & meta-analysis of locoregional therapies for #HCC in @jama.com network open

βœ…Inclusion:
RCTs with PFS and OS as endpoints

βœ…Conclusions:
Resection > thermal ablation ~ RT ~ HAIC > embolization

#oncsky #radonc #radsky #liversky

ja.ma/3ONRpQ1

06.12.2024 12:45 β€” πŸ‘ 19    πŸ” 7    πŸ’¬ 3    πŸ“Œ 0

@anjanapillaimd is following 20 prominent accounts